Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy? Commentary

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	14-15
Number of pages	2
Journal	Nature Clinical Practice Neurology
Volume	3
Issue number	1
DOIs	https://doi.org/10.1038/ncpneuro0375
State	Published - Jan 2007

ASJC Scopus subject areas

@article{c365091c80794a04a4de51f3955ca7bd,

title = "Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy? Commentary",

author = "Gilbert, {Mark R.} and Lang, {Frederick F.}",

year = "2007",

month = jan,

doi = "10.1038/ncpneuro0375",

language = "English (US)",

volume = "3",

pages = "14--15",

journal = "Nature Clinical Practice Neurology",

issn = "1745-834X",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Should patients with anaplastic oligodendroglial tumors receive adjuvant chemotherapy? Commentary

AU - Gilbert, Mark R.

AU - Lang, Frederick F.

PY - 2007/1

Y1 - 2007/1

UR - http://www.scopus.com/inward/record.url?scp=33846082648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846082648&partnerID=8YFLogxK

U2 - 10.1038/ncpneuro0375

DO - 10.1038/ncpneuro0375

M3 - Short survey

C2 - 17205067

AN - SCOPUS:33846082648

SN - 1745-834X

VL - 3

SP - 14

EP - 15

JO - Nature Clinical Practice Neurology

JF - Nature Clinical Practice Neurology

IS - 1

ER -